Feasible concomitant treatment with eltrombopag and oral anticoagulation in a patient with chronic immune thrombocytopenia and severe cardiac comorbidities.
作者信息
Sanchez-Gonzalez Blanca, Ancochea Agueda, Garcia-Pallarols Francesc, Jimenez Carmen, Pedro Carme, Besses Carles
机构信息
Department of Hematology, Hospital del Mar-IMIM , Barcelona , Spain.
出版信息
Platelets. 2014;25(4):309-10. doi: 10.3109/09537104.2013.770137. Epub 2013 Feb 27.
PMID:23444985
Abstract
摘要
相似文献
1
Feasible concomitant treatment with eltrombopag and oral anticoagulation in a patient with chronic immune thrombocytopenia and severe cardiac comorbidities.艾曲泊帕与口服抗凝剂对一名患有慢性免疫性血小板减少症及严重心脏合并症患者的可行性联合治疗。
Platelets. 2014;25(4):309-10. doi: 10.3109/09537104.2013.770137. Epub 2013 Feb 27.
2
Long-term follow-up of concomitant treatment with romiplostim and warfarin in a patient with immune thrombocytopenia and severe cardiac comorbidities.
Platelets. 2013;24(3):242-3. doi: 10.3109/09537104.2012.686074. Epub 2012 May 30.
3
Immune thrombocytopenia and anticoagulation: the role of romiplostim in the early treatment.免疫性血小板减少症与抗凝：罗米司亭在早期治疗中的作用
Br J Haematol. 2012 Jun;157(5):639-41. doi: 10.1111/j.1365-2141.2012.09051.x. Epub 2012 Feb 14.
4
Safety and efficacy of romiplostim in patients with eltrombopag-resistant or -intolerant immune thrombocytopenia.罗米司亭在艾曲泊帕耐药或不耐受的免疫性血小板减少症患者中的安全性和有效性。
Br J Haematol. 2013 Oct;163(2):286-9. doi: 10.1111/bjh.12483. Epub 2013 Jul 17.
5
Pseudothrombocytopenia in a patient receiving romiplostim for immune thrombocytopenic purpura.一名接受罗米司亭治疗免疫性血小板减少性紫癜的患者出现假性血小板减少症。
Ann Hematol. 2014 May;93(5):899-900. doi: 10.1007/s00277-013-1907-x. Epub 2013 Oct 1.
6
Comment on: Use of thrombopoietin receptor agonist (romiplostim) in neonatal autoimmune thrombocytopenia due to maternal immune thrombocytopenia.评论：血小板生成素受体激动剂（罗米司亭）在因母亲免疫性血小板减少症导致的新生儿自身免疫性血小板减少症中的应用。
Pediatr Blood Cancer. 2019 Jun;66(6):e27706. doi: 10.1002/pbc.27706. Epub 2019 Mar 11.
7
Treatment of chronic immune thrombocytopenia in children with romiplostim.用罗米司亭治疗儿童慢性免疫性血小板减少症。
Lancet. 2016 Jul 2;388(10039):4-6. doi: 10.1016/S0140-6736(16)00589-4. Epub 2016 Apr 18.
8
Profound thrombocytopenia in patient with ITP treated with chemotherapy for breast cancer and subsequent remission after romiplostim.
Ann Hematol. 2013 Aug;92(8):1145-6. doi: 10.1007/s00277-013-1677-5. Epub 2013 Jan 18.
9
Effectiveness of thrombopoietin-receptor agonists in the treatment of refractory immune thrombocytopenia associated to systemic lupus erythematosus.血小板生成素受体激动剂治疗系统性红斑狼疮相关难治性免疫性血小板减少症的疗效
J Rheumatol. 2014 Sep;41(9):1895-6. doi: 10.3899/jrheum.140080.
10
High response rate but short-term effect of romiplostim in paediatric refractory chronic immune thrombocytopenia.罗米司亭治疗儿童难治性慢性免疫性血小板减少症的缓解率高但为短期效应。
Br J Haematol. 2014 May;165(3):419-21. doi: 10.1111/bjh.12766. Epub 2014 Feb 1.
引用本文的文献
1
Cerebral venous thrombosis in refractory idiopathic thrombocytopenia treated with eltrombopag.艾曲泊帕治疗难治性特发性血小板减少症时发生的脑静脉血栓形成
Ann Indian Acad Neurol. 2016 Oct-Dec;19(4):532-533. doi: 10.4103/0972-2327.194468.
Zotero 插件